SIM
IART icon

SummerHaven Investment Management’s Integra LifeSciences IART Stock Holding History

SummerHaven Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$948K Hold
52,789
– – 0.51% 89
2026
Q1 		$497K Sell
52,789
-11,978
-18% -$132K 0.31% 173
2025
Q4 		$804K Hold
64,767
– – 0.46% 126
2025
Q3 		$928K Buy
+64,767
New +$887K 0.54% 62

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SummerHaven Investment Management's IART Position: Q2 2026 in Review

SummerHaven Investment Management held its Integra LifeSciences (IART) position steady in Q2 2026 at 52,789 shares worth $948K. The position accounts for 0.51% of the portfolio, ranked #89.

SummerHaven Investment Management first reported a position in IART in Q3 2025 and has held it in 4 quarters since. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • SummerHaven Investment Management held 52,789 shares of Integra LifeSciences worth $948K as of Q2 2026.
  • SummerHaven Investment Management left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up 0.51% of SummerHaven Investment Management's portfolio in Q2 2026, its #89 holding.
  • SummerHaven Investment Management first reported a position in Integra LifeSciences in Q3 2025 and has held it in 4 quarters since.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on SummerHaven Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.